Andere Kunden interessierten sich auch für
![Modellierung heterozyklischer Hybride als Malariawirkstoffe]( "Modellierung heterozyklischer Hybride als Malariawirkstoffe")
Modellierung heterozyklischer Hybride als Malariawirkstoffe79,90 €![Modelowanie hybryd heterocyklicznych jako ¿rodków przeciwmalarycznych]( "Modelowanie hybryd heterocyklicznych jako ¿rodków przeciwmalarycznych")
Modelowanie hybryd heterocyklicznych jako ¿rodków przeciwmalarycznych51,99 €![Modelação de híbridos heterocíclicos como agentes antimaláricos]( "Modelação de híbridos heterocíclicos como agentes antimaláricos")
Modelação de híbridos heterocíclicos como agentes antimaláricos51,99 €![Modélisation d'Hybrides Hétérocycliques comme Agents Antipaludiques]( "Modélisation d'Hybrides Hétérocycliques comme Agents Antipaludiques")
Modélisation d'Hybrides Hétérocycliques comme Agents Antipaludiques51,99 €![Modellazione di ibridi eterociclici come agenti antimalarici]( "Modellazione di ibridi eterociclici come agenti antimalarici")
Modellazione di ibridi eterociclici come agenti antimalarici51,99 €![Obesity and physico-chemical phenomena. In-silico studies]( "Obesity and physico-chemical phenomena. In-silico studies")
Obesity and physico-chemical phenomena. In-silico studies40,99 €![DFT study on the chelating agents for treatment of Iron overload]( "DFT study on the chelating agents for treatment of Iron overload")
DFT study on the chelating agents for treatment of Iron overload30,99 €
This research focuses on the application of QSAR and molecular docking methods to model antimalarial hybrid molecules. Multidimensional molecular descriptors (1D, 2D, 3D) were calculated using density functional theory (DFT) with the hybrid function B3LYP and base 6-31G. Particular attention was paid to molecular docking with respect to Plasmodium falciparum dihydrofolate reductase (DHFR), in both its wild-type and mutant forms. This study enabled us to visualize and understand how the pharmacophores of quinoline-triazine derivatives interact with the DHFR protein. Critical amino acids involved in drug resistance were identified, including those responsible for reduced inhibitor efficacy, thus offering prospects for the development of new antimalarial molecules capable of overcoming this resistance.